康缘药业(600557) - 2018 Q1 - 季度财报

Financial Performance - Net profit attributable to shareholders increased by 8.95% to CNY 94,617,166.68 year-on-year[5] - Operating income rose by 16.46% to CNY 895,793,447.02 compared to the same period last year[5] - Basic earnings per share increased by 7.14% to CNY 0.15 per share[5] - Total operating revenue for Q1 2018 reached CNY 895,793,447.02, an increase of 16.5% compared to CNY 769,185,721.04 in the same period last year[32] - Net profit for Q1 2018 was CNY 95,086,207.00, representing a growth of 8.5% compared to CNY 87,903,354.64 in Q1 2017[32] - The net profit attributable to shareholders of the parent company was CNY 94,617,166.68, up from CNY 86,844,327.44, reflecting a growth of 8.6% year-over-year[33] - The total comprehensive income for the period was CNY 95,086,207.00, compared to CNY 87,901,728.64 in the same quarter last year[33] Cash Flow - Net cash flow from operating activities surged by 1,906.76% to CNY 195,452,254.85 compared to the previous year[5] - The company's operating cash flow increased by 64.96% to CNY 1,219,785,773.64 compared to CNY 739,447,721.28 in the previous year[19] - The net cash flow from operating activities for Q1 2018 was ¥193,568,960.82, a significant increase from ¥48,550,844.99 in the same period last year, representing a growth of approximately 299%[42] - The total cash outflow from operating activities was ¥918,710,582.18, up from ¥655,011,586.58 in the previous year, reflecting a rise of approximately 40%[42] - The net cash outflow from investing activities was CNY 92,437,020.33, compared to a larger outflow of CNY 200,473,277.95 in the previous year[40] - The net cash flow from financing activities was -¥202,510,896.94, compared to a positive net flow of ¥61,421,124.94 in the same quarter last year[43] Assets and Liabilities - Total assets decreased by 2.81% to CNY 5,242,281,519.06 compared to the end of the previous year[5] - The total assets decreased from CNY 5,393,709,954.91 at the beginning of the year to CNY 5,242,281,519.06, a reduction of approximately 2.8%[25] - Current liabilities totaled CNY 1,359,913,169.09, down from CNY 1,582,653,543.58 at the start of the year, indicating a reduction of 14.1%[29] - The total liabilities decreased to CNY 1,434,160,526.67 from CNY 1,659,527,699.04, reflecting a reduction of 13.5%[29] - The company's retained earnings increased to CNY 2,078,094,745.83, up from CNY 1,984,010,451.55, indicating a growth of 4.7%[29] Shareholder Information - The total number of shareholders reached 31,426 at the end of the reporting period[11] - Jiangsu Kangyuan Group Co., Ltd. held 28.06% of the shares, making it the largest shareholder[11] Expenses - Total operating costs amounted to CNY 788,360,937.57, up 17.7% from CNY 669,903,170.15 year-on-year[32] - The company reported a significant increase in sales expenses, which rose to CNY 421,580,352.24, up 25.3% from CNY 336,496,639.08 year-on-year[32] - The company's sales expenses increased to CNY 374,561,615.09 from CNY 275,995,438.59, marking a rise of 35.5%[35] - The financial expenses increased by 53.82% to CNY 16,602,715.51, mainly due to higher bank acceptance bill expenses[17] - The financial expenses rose to CNY 14,584,471.65, compared to CNY 8,728,363.12, indicating an increase of 67.5%[35] Cash and Equivalents - Cash and cash equivalents decreased by 34.44% to CNY 193,614,162.37 due to loan repayments[14] - The company's cash and cash equivalents decreased to CNY 122,258,974.15 from CNY 216,743,042.22, a decline of 43.7%[27] - The cash and cash equivalents at the end of the period were CNY 193,614,162.37, down from CNY 139,723,929.52 at the end of Q1 2017[40] - The ending balance of cash and cash equivalents was ¥122,258,974.15, an increase from ¥62,260,322.83 at the end of Q1 2017[43] Investments - The cash flow from investing activities surged by 275,257.88% to CNY 111,244,582.59, primarily due to the purchase of financial products[19] - The company received government subsidies amounting to CNY 4,475,082.76 related to its normal business operations[7] - The company received ¥30,050,000.00 from investment recoveries during the quarter, with no comparable figure from the previous year[42] - The cash paid for the purchase of fixed assets and intangible assets was ¥60,329,741.98, slightly up from ¥56,283,011.95 in Q1 2017[42]